Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duliang soft capsule for chronic daily headache
ChiCTR-TRC-13003459Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Duliang in chronic daily headache (CDH) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Headache-free rate. Started Jan 2011; status: completed.
02
Drugs
Duliang
03
Conditions
chronic daily headache (CDH)
Beyond the preview
Go deeper on ChiCTR-TRC-13003459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003459.